Quaker Houghton · NYSE:KWR
Quaker Houghton — Q4 2025 Earnings Presentation
15 slides from Quaker Houghton's earnings presentation, Feb 24, 2026
Slide 1: Fourth Quarter and Full Year 2025 Results
Quaker Houghton Fourth Quarter and Full Year 2025 Results Investor Conference Call
Slide 2: Forward-Looking Statements
Forward-Looking Statements Forward-Looking Statements This presentation contains “forward-looking statements” that fall under the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 and the Securities Act of 1933, as amended. These statements can be identified by the fact
Slide 3: Non-GAAP Measures
Non-GAAP Measures The information in this press release includes non-GAAP (unaudited) financial information that includes EBITDA, adjusted EBITDA, adjusted EBITDA margin, non-GAAP operating income, non-GAAP operating margin, non-GAAP net income and non-GAAP earnings per diluted share. The Company be
Slide 4: Speakers
Speakers Joe Berquist Chief Executive Officer, President Tom Coler Executive Vice President, Chief Financial Officer Robert T. Traub Senior Vice President, General Counsel & Corporate Secretary John Dalhoff Investor Relations 4 ©2026 Quaker Houghton. All Rights Reserved
Slide 5: Q4'25 and FY'25 Highlights
Q4’25 and FY’25 Highlights Q4’25 $72M FY’25 $299M Adjusted Adjusted $468M EBITDA1 $1,889M EBITDA1 Net Sales Net Sales $47M $136M Operating Operating $1.65 Cash Flow $7.02 Cash Flow Non-GAAP 2.3x Non-GAAP Earnings per Diluted Share1 Leverage Earnings per Diluted Share1 $42M Ratio 1,2 Share Repurchase
Slide 6: Financial Snapshot
Financial Snapshot (Unaudited; Dollars in millions, unless otherwise noted) Q4 2025 Q4 2024 Variance(1) YTD 2025 YTD 2024 Variance(1) GAAP Net sales $ 468.5 $ 444.1 $ 24.4 5.5% $ 1,888.6 $ 1,839.7 $ 48.9 2.7% Gross profit 165.5 156.2 9.3 6.0% 679.4 686.0 (6.7) (1.0%) Gross margin (%) 35.3% 35.2% 0.2
Slide 7: Total Company Volume Trend
Total Company Volume Trend1 (kilograms, in thousands) Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Sales volumes slightly decreased in Q4’25 compared to Q4’24, primarily due to softer underlying end market activity, partially offset by new business
Slide 8: Adjusted EBITDA
Adjusted EBITDA1 (dollars in millions) $320 $311 $299 $72 $274 $65 $257 2021 2022 2023 2024 2025 Q4 2025 Q4 2024 Generated $72m of adjusted EBITDA in Q4’25, an increase of 11% year-over-year 1 This is a non-GAAP measure, refer to the reconciliations of our non-GAAP measures to their most comparable
Slide 9: Leverage and Liquidity Update
Leverage and Liquidity Update Net Debt and Leverage Ratio1 • Total debt of $871 million (Dollars in Millions) • Cash and cash equivalents of $180 million $815 $750 $759 $759 $736 $765 $787 $774 $753 • Net debt of $691 million $735 $703 $691 $696 • Leverage of 2.3x as of December 31, 20251 $628 $561
Slide 10: Appendix
Appendix Actual and Non-GAAP Results
Slide 11: Non-GAAP Gross Profit and Operating Reconciliation
Non-GAAP Gross Profit and Operating Reconciliation (Unaudited; Dollars in thousands, unless otherwise noted) Three Months Ended Twelve Months Ended December 31, December 31, Non-GAAP Gross Profit and Margin Reconciliations 2025 2024 2025 2024 Gross profit $ 165,524 $ 156,200 $ 679,372 $ 686,030 Acqu
Slide 12: Adjusted EBITDA Reconciliation
Adjusted EBITDA Reconciliation (Unaudited; Dollars in thousands, unless otherwise noted) Three Months Ended December 31, EBITDA, Adjusted EBITDA, Adjusted EBITDA Margin and Non-GAAP Net Income Reconciliations 2025 2024 Net income attributable to Quaker Chemical Corporation $ 20,701 $ 14,186 Deprecia
Slide 13: Adjusted EBITDA Reconciliation
Adjusted EBITDA Reconciliation (Unaudited; Dollars in thousands, unless otherwise noted) Twelve Months Ended December 31, EBITDA, Adjusted EBITDA, and Adjusted EBITDA Margin Reconciliations: 2025 2024 2023 2022 2021 Net income attributable to Quaker Chemical Corporation $ (2,488) $ 116,644 $ 112,748
Slide 14: Non-GAAP EPS Reconciliation
Non-GAAP EPS Reconciliation Three Months Ended Twelve Months Ended December 31, December 31, Non-GAAP Earnings per Diluted Share Reconciliations: 2025 2024 2025 2024 GAAP earnings per diluted share attributable to Quaker Chemical Corporation common shareholders $ 1.18 $ 0.81 $ (0.14) $ 6.51 Equity i
Slide 15: Segment Performance
Segment Performance (Unaudited; Dollars in thousands, except per share amounts) Three Months Ended Twelve Months Ended December 31, December 31, 2025 2024 2025 2024 Net Sales Americas $ 207,772 $ 208,585 $ 865,332 $ 882,131 EMEA 135,009 125,877 548,110 536,435 Asia/Pacific 125,697 109,624 475,192 42